The VLDL apoB-@ pool size was also significantly decreased by sitagliptin therapy ( -@ % , p = @ ) , mainly because of a reduction in the hepatic secretion of these lipoproteins , although this difference did not reach statistical significance ( -@ % , p = @ ) .